Skip to main content

Find Clinical Trials

Home
Conditions
Inflammatory Bowel Disease

Clinical trial condition

Inflammatory Bowel Disease

Explore clinical trials studying Inflammatory Bowel Disease. Study availability and eligibility vary by location and protocol.

226 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Inflammatory Bowel Disease trial results

Completed

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

NCT00175292

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +5 more
Locations: Health Sciences Centre Calgary, Alberta, Canada

Royal Alexandra Hospital Edmonton, Alberta, Canada

Walter Mackenzie Health Sciences Centre Edmonton, Alberta, Canada

St. Paul's Hospital Vancouver, British Columbia, Canada

View all 17 locations

View Trial Details

Completed

The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels

NCT00167882

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +9 more
Locations: Maasland Hospital Sittard, Netherlands

View Trial Details

Completed

A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease

NCT00035074

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +3 more
Locations: Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Johns Hopkins Crohn's Disease and Ulcerative Colitis Study

NCT01169207

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)

NCT01169194

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations: Johns Hopkins University School of Medicine Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

NCT05633771

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +3 more
Locations: Sandoz Investigational Site Belgium Aalst, Belgium

Sandoz Investigational Site Belgium Antwerp, Belgium

Sandoz Investigational Site Belgium Bonheiden, Belgium

Sandoz Investigational Site Belgium Brussels, Belgium

View all 51 locations

View Trial Details